Boditech Med Inc. (KOSDAQ: 206640)

Boditech Med Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	141,863	134,219	118,077	157,708	144,131	72,799
Other Revenue	0	-	-	-	-	-
Revenue	141,863	134,219	118,077	157,708	144,131	72,799
Revenue Growth (YoY)	10.70%	13.67%	-25.13%	9.42%	97.99%	9.96%
Cost of Revenue	55,278	53,724	47,443	59,516	46,697	31,977
Gross Profit	86,584	80,495	70,634	98,192	97,434	40,821
Selling, General & Admin	33,910	30,836	26,370	24,177	16,909	15,071
Research & Development	15,256	13,410	14,676	14,258	11,585	8,543
Other Operating Expenses	1,036	972.66	837.56	800.56	484.26	392.19
Operating Expenses	56,085	52,238	45,962	46,256	31,418	25,806
Operating Income	30,499	28,257	24,671	51,936	66,016	15,015
Interest Expense	-372.4	-350.39	-203.92	-196.5	-466.69	-1,731
Interest & Investment Income	1,182	663.8	332.21	344.11	97.28	112.78
Earnings From Equity Investments	165.56	312.38	-	-	-147.21	-
Currency Exchange Gain (Loss)	-608.35	1,660	1,887	3,486	-2,833	546.7
Other Non Operating Income (Expenses)	777.57	711.81	568.61	1,106	-541.45	-445.88
EBT Excluding Unusual Items	31,644	31,255	27,255	56,676	62,125	13,498
Gain (Loss) on Sale of Investments	330.46	354.43	-330.2	-470.48	182.37	-219.17
Gain (Loss) on Sale of Assets	117.91	-48.18	43.62	-86.54	147.31	-4.43
Asset Writedown	-	-	-35.86	-79.44	-2,327	-211.54
Other Unusual Items	-	6.01	32.8	-	46.61	16.88
Pretax Income	32,092	31,567	26,965	56,039	60,174	13,079
Income Tax Expense	4,609	4,899	1,684	8,644	11,862	1,182
Earnings From Continuing Operations	27,483	26,668	25,281	47,395	48,312	11,897
Minority Interest in Earnings	-182.99	-721.75	-1,130	-3,028	-2,823	-247.03
Net Income	27,300	25,947	24,152	44,367	45,489	11,650
Net Income to Common	27,300	25,947	24,152	44,367	45,489	11,650
Net Income Growth	5.52%	7.43%	-45.56%	-2.47%	290.47%	-
Shares Outstanding (Basic)	22	22	22	23	23	23
Shares Outstanding (Diluted)	22	22	22	23	23	23
Shares Change (YoY)	-0.08%	-1.77%	-2.41%	-0.47%	0.14%	-0.24%
EPS (Basic)	1242.40	1181.10	1079.94	1937.17	1978.15	506.66
EPS (Diluted)	1242.03	1181.00	1079.94	1936.26	1975.90	506.66
EPS Growth	5.58%	9.36%	-44.23%	-2.01%	289.98%	-
Free Cash Flow	17,753	29,695	7,808	31,697	40,565	12,535
Free Cash Flow Per Share	807.92	1351.72	349.13	1383.14	1761.80	545.14
Dividend Per Share	200.000	200.000	150.000	200.000	200.000	50.000
Dividend Growth	33.33%	33.33%	-25.00%	0%	300.00%	0%
Gross Margin	61.03%	59.97%	59.82%	62.26%	67.60%	56.07%
Operating Margin	21.50%	21.05%	20.89%	32.93%	45.80%	20.63%
Profit Margin	19.24%	19.33%	20.45%	28.13%	31.56%	16.00%
Free Cash Flow Margin	12.51%	22.12%	6.61%	20.10%	28.14%	17.22%
EBITDA	38,885	36,489	32,144	57,977	71,406	20,098
EBITDA Margin	27.41%	27.19%	27.22%	36.76%	49.54%	27.61%
D&A For EBITDA	8,386	8,232	7,473	6,041	5,389	5,083
EBIT	30,499	28,257	24,671	51,936	66,016	15,015
EBIT Margin	21.50%	21.05%	20.89%	32.93%	45.80%	20.63%
Effective Tax Rate	14.36%	15.52%	6.24%	15.43%	19.71%	9.04%
Advertising Expenses	-	1,149	962.7	686.79	318.55	684.25

Source: S&P Capital IQ. Standard template. Financial Sources.